Queensberry builds the engineering that sits underneath deep technology products and holds the intellectual property behind them — including our own platform, metabolica.app, a clinical point-of-care insulin diagnostic platform.
Queensberry is a software engineering and applied research company based in Margaret River, Western Australia. The registered entity is Queensberry Consulting Pty Ltd.
We build the software, the AI layer and the integration work that sits underneath deep technology products, and we hold the intellectual property behind them.
Our directors have spent three decades delivering production systems across enterprise banking, manufacturing, resources and tourism. That history shapes how we work now: careful engineering, real users, and systems that survive contact with the field.
Custom application development on modern cloud native stacks, including Angular, React, TypeScript and AWS. We work in sectors where the data is messy, the domain is technical and the answer has to be defensible.
Predictive and machine learning layers built on real clinical and operational data, and the integration work that connects instruments, wearables, devices and records into something a practitioner can actually use.
From client engineering to applied AI and integration, Queensberry brings the same rigorous, technically-led approach to every engagement — including our own product, Metabolica.
Built in-house by Queensberry, Metabolica is the first platform globally to combine real-time point-of-care insulin measurement, multi-device wearable biometric data, and AI-powered metabolic risk prediction in a single clinician-accessible platform.
The Lumos Diagnostics POC reader measures fasting insulin from a single blood drop in under 5 minutes — at the point of care, no laboratory required.
Continuous glucose, HRV, sleep quality and activity data pulled via API from 15+ wearable platforms including Garmin, Apple Health, Oura, Whoop and Dexcom.
Combined insulin and biometric data is processed by a machine learning model generating a personalised metabolic risk profile, updated in real time.
Results displayed in a secure clinician-accessible dashboard, enabling remote monitoring, trend analysis, and metabolic risk assessment over time.
In-clinic metabolic screening and remote monitoring for at-risk patients.
Perioperative metabolic risk assessment — insulin resistance as a modifiable surgical risk factor.
Workforce metabolic health baseline and evidence-based prevention program support.
Population health monitoring for community sport, regional health, and chronic disease prevention.
Queensberry Consulting Pty Ltd was named a recipient of the Innovation Booster Grant 2026, a Western Australian Government program administered by the Department of Energy and Economic Diversification to back early-stage founders and innovation-driven SMEs to strengthen capability and commercialise innovative projects.
Program administered by the Department of Energy and Economic Diversification, Government of Western Australia.
Queensberry is led by three directors with complementary expertise across biomedical science, software engineering, financial management, and technology commercialisation.
We welcome enquiries from practitioners, corporates, research partners, and investors.
Address
47 Sheridan Road, Margaret River WA 6285
Phone
0401 557 671
Platform
metabolica.app
ABN
78 108 548 269
If you are a GP, anaesthetist, exercise physiologist, or metabolic health specialist interested in the Metabolica platform for clinical use or the validation study, please email info@queensberryconsulting.com.au with the subject line Practitioner Enquiry.
For CRC-P partnership, FHRI research collaboration, or corporate wellness pilot enquiries, please email with the subject line Research Partnership or Corporate Enquiry.